Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$63.15 - $72.88 $1.31 Million - $1.51 Million
-20,705 Reduced 36.5%
36,020 $2.47 Million
Q1 2024

Apr 12, 2024

SELL
$71.58 - $87.29 $1.97 Million - $2.4 Million
-27,483 Reduced 32.64%
56,725 $4.16 Million
Q4 2023

Feb 09, 2024

BUY
$73.27 - $83.09 $2.01 Million - $2.28 Million
27,463 Added 48.4%
84,208 $6.82 Million
Q3 2023

Oct 12, 2023

SELL
$73.94 - $80.67 $106,991 - $116,729
-1,447 Reduced 2.49%
56,745 $4.25 Million
Q2 2023

Jul 14, 2023

BUY
$76.01 - $86.7 $4.42 Million - $5.05 Million
58,192 New
58,192 $4.48 Million
Q1 2023

Apr 24, 2023

SELL
$77.31 - $88.08 $19.4 Million - $22.1 Million
-250,858 Closed
0 $0
Q4 2022

Feb 09, 2023

BUY
$62.32 - $89.47 $15.6 Million - $22.4 Million
250,858 New
250,858 $21.5 Million
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $3.85 Million - $4.33 Million
-66,666 Closed
0 $0
Q1 2022

Apr 19, 2022

BUY
$57.92 - $72.58 $2.83 Million - $3.55 Million
48,898 Added 275.2%
66,666 $3.96 Million
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $1.13 Million - $1.23 Million
17,768 New
17,768 $1.22 Million
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $10.7 Million - $12.4 Million
-147,473 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$62.63 - $80.22 $5.4 Million - $6.92 Million
86,254 Added 140.89%
147,473 $11 Million
Q4 2019

Feb 13, 2020

BUY
$61.62 - $67.78 $3.77 Million - $4.15 Million
61,219 New
61,219 $3.98 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.